Apogee buy delivers eczema trial win for AbbVie
AbbVie's long-acting IL-13 inhibitor zumilokibart, part of its $10.9bn Apogee buy, has shown efficacy in atopic dermatitis and will move into phase 3.
Two men charged with infiltrating fake Ozempic into US
Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.
Lilly fleshes out triple G data in diabetes and obesity
Eli Lilly has revealed more data with its triple G agonist retatrutide, boosting its credentials as the next big thing in cardiometabolic diseases.
PhRMA hires ex-House Majority Leader Eric Cantor as its CEO
Former Republican lawmaker Eric Cantor has been named as the new CEO of US pharma group PhRMA, replacing long-serving Stephen Ubl.
uniQure falls on long-term Huntington's gene therapy data
uniQure's latest data drop for its gene therapy for Huntington's disease, under review in the US and UK, has spooked investors.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
3rd Annual Personalized Cancer Vaccine Summit 2026 | Decembe...
The 3rd Annual Personalized Cancer Vaccine Summit brings together leaders from across companies to share data-driven insights
CPHI Milan 2026 showcases new Sustainability Summit
The first-time event will bring delegates together to discuss sustainability challenges
Pharmaceutical thought leaders gather at CPHI Milan 2026
Industry leaders will address topics such as manufacturing transformation and future therapies
5th Sustainability in Life Sciences Summit
Join the global sustainability community this November in Boston
CPHI Milan Leadership Summit returns for 2026
Senior pharma leaders will tackle resilience, policy, and industry transformation at CPHI Milan